SuperworthElectromed EPS ELMD
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- $1.31
- Latest quarter, Q4 FY26
- $0.39
- +56% on a year earlier
- Fiscal year 2026
- $1.31
- +56% on the year before
Electromed's earnings per share was $1.31 over the twelve months to Jun 30, 2026, up 56% on a year earlier.
In its latest quarter, Q4 FY26, it was $0.39, up 56% on the same quarter a year before.
Over the five fiscal years to FY2026 it grew 37% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2026 | $1.31 | +56% |
| FY2025 | $0.84 | +45% |
| FY2024 | $0.58 | +61% |
| FY2023 | $0.36 | +38% |
| FY2022 | $0.26 | −4% |
| FY2021 | $0.27 | −43% |
| FY2020 | $0.47 | +104% |
| FY2019 | $0.23 | +10% |
| FY2018 | $0.21 | −19% |
| FY2017 | $0.26 | −4% |
| FY2016 | $0.27 | +108% |
| FY2015 | $0.13 | n/a |
| FY2014 | −$0.15 | n/a |
| FY2013 | −$0.16 | −900% |
| FY2012 | $0.02 | −86% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q4 FY26 | $0.39 | +56% | $1.31 | |
| Q3 FY26 | $0.35 | +67% | $1.17 | |
| Q2 FY26 | $0.32 | +45% | $1.03 | |
| Q1 FY26 | $0.25 | +56% | $0.93 | |
| Q4 FY25 | $0.25 | +25% | $0.84 | |
| Q3 FY25 | $0.21 | +24% | $0.79 | |
| Q2 FY25 | $0.22 | +16% | $0.75 | |
| Q1 FY25 | $0.16 | +700% | $0.72 | |
| Q4 FY24 | $0.20 | +67% | $0.58 | |
| Q3 FY24 | $0.17 | +42% | $0.50 | |
| Q2 FY24 | $0.19 | +73% | $0.45 | |
| Q1 FY24 | $0.02 | +100% | $0.37 |
Against its peers
Companies in Healthcare nearest Electromed's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| ELMDElectromed | $1.31 | +56% a year |
| NATRNatures Sunshine Products | $1.01 | +36% a year |
| UTMDUtah Medical Products | $3.28 | −12% a year |
| PLXProtalix BioTherapeutics | $0.23 | +283% a year |
| PDEXPro DEX | $4.11 | +52% a year |
| INFUInfuSystem | $0.41 | +78% a year |
| VMDViemed Healthcare | $0.36 | +6% a year |
| EMBCEmbecta | $1.47 | +3% a year |
| ARVNArvinas | $0.16 | |
| NRCNRC Health | $0.25 | −67% a year |
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| Peer median | $0.71 |
Where Electromed ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Electromed
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.